7Baggers
 kros: wells fargo lowers price target to $23, maintains overweig  GuruFocus Tue, 11 Nov 2025 15:32:35 GMT
 Keros Therapeutics Earns Relative Strength Rating Upgrade  Investor's Business Daily Tue, 11 Nov 2025 08:00:00 GMT
 Keros Therapeutics Drives Nasdaq Composite Momentum In Medicine  Kalkine Media Tue, 11 Nov 2025 08:00:00 GMT
 kros vs. argx: which stock is the better value option?  Yahoo Finance Mon, 10 Nov 2025 16:40:04 GMT
 fy2025 eps estimate for keros therapeutics lifted by analyst  MarketBeat Mon, 10 Nov 2025 07:24:51 GMT
 What is HC Wainwright's Estimate for KROS FY2025 Earnings?  MarketBeat Mon, 10 Nov 2025 07:24:50 GMT
 FY2025 EPS Forecast for Keros Therapeutics Raised by Analyst  MarketBeat Mon, 10 Nov 2025 07:24:49 GMT
 Precision Trading with Keros Therapeutics Inc. (KROS) Risk Zones  news.stocktradersdaily.com Sun, 09 Nov 2025 22:30:02 GMT
 keros therapeutics reports strong revenue growth  TipRanks Thu, 06 Nov 2025 05:13:51 GMT
 keros therapeutics reports q3 eps (18c), consensus (92c)  TipRanks Thu, 06 Nov 2025 02:23:53 GMT
 td cowen maintains keros therapeutics(kros.us) with hold rating  富途牛牛 Thu, 06 Nov 2025 01:34:49 GMT
 kros surpasses revenue expectations and advances clinical trials  GuruFocus Wed, 05 Nov 2025 22:07:08 GMT
 biopharma company keros' q3 net loss narrows on takeda license revenue  MarketScreener Wed, 05 Nov 2025 21:14:46 GMT
 Keros Therapeutics Reports Third Quarter 2025 Financial Results  Yahoo Finance Wed, 05 Nov 2025 08:00:00 GMT
 Keros Therapeutics Reports Strong Revenue Growth  TipRanks Wed, 05 Nov 2025 08:00:00 GMT
 published on: 2025-11-03 06:15:55  newser.com Mon, 03 Nov 2025 12:15:55 GMT
 published on: 2025-11-02 04:38:21  newser.com Sun, 02 Nov 2025 09:38:21 GMT

Keros Therapeutics, Inc
(NASDAQ:KROS) 

KROS stock logo

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, wh...

Founded: 2015
Full Time Employees: 32
CEO: Jasbir S. Seehra  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends